TABLE 2.
Summary of potential metabolites in candidate pathways responsible for donor MaS and graft failure.
MaS vs. Non-MaS | Structure | ID | Category | Statistics | Biological Involvement | |||||||
Metabolites | Formula | KEGG | HMDB | LIPID MAPS | Super Class | Main Class | Sub Class | FC/HR (95%CI) | P-value | Trend-a | Pathway | Function |
PC(20:5/16:0) | C44H7 8NO8P | C00157 | HMDB00 08495 | LMGP010 11932 | Lipids and lipid-like molecules | Glycero phospho lipids | Glycero phosphocholines | 0.45 | 0.041 | down | Linoleic acid/Glycero phospholipid metabolism | Known as phosphatidylcholine, consists of one chain of eicosapentaenoic acid at the C-1 position and one chain of palmitic acid at the C-2 position, involved in metabolism and signaling. |
Linoleic acid | C18H3 2O2 | C01595 | HMDB00 00673 | LMFA010 30120 | Lipids and lipid-like molecules | Fatty Acyls | Lineolic acids and derivatives | 2.57 | 0.004 | up | Linoleic acid metabolism | Known as an essential fatty acid in human nutrition because it cannot be synthesized by humans. Used in the biosynthesis of prostaglandins and cell membranes. Associated with isovaleric acidemia, which is an inborn error of metabolism. |
PE(20:4/22:6) | C47H74 NO8P | C00350 | HMDB00 09408 | LMGP020 10961 | Lipids and lipid-like molecules | Glycero phospholipids | Glycerophospho ethanolamines | 0.31 | 0.042 | down | Glycero phospholipid metabolism | Also named as phosphatidylethanolamine |
PE(20:5/18:2) | C43H72 NO8P | C00350 | HMDB00 09456 | LMGP020 10974 | Lipids and lipid-like molecules | Glycero phospholipids | Glycerophospho ethanolamines | 0.29 | 0.036 | down | Glycero phospholipid metabolism | Also named as delta7- Avenasterol, as intermediate in the biosynthesis of steroids |
LysoPC(20:3) | C28H5 2NO7P | C04230 | HMDB00 10393 | LMGP01 050139 | Lipids and lipid-like molecules | Glycero phospholipids | Glycero phosphocholines | 2.00 | 0.010 | up | Glycero phospholipid metabolism | Known as glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. |
LysoPC(20:4) | C28H5 0NO7P | C04230 | HMDB0 010395 | Lipids and lipid-like molecules | Glycero phospholipids | Glyceropho sphocholines | 2.21 | 0.008 | up | Glycero phospholipid metabolism | Known as lysophospholipids which has a role in lipid signaling by acting on lysophospholipid receptors. | |
LysoPC(22:4) | C30H5 4NO7P | C04230 | HMDB00 10401 | Lipids and lipid-like molecules | Glycero phospholipids | Glyceropho sphocholines | 2.12 | 0.021 | up | Glycero phospholipid metabolism | Known as lysophospholipids which has a role in lipid signaling by acting on lysophospholipid receptors. | |
LysoPC(22:5) | C30H5 2NO7P | C04230 | HMDB00 10403 | LMGP010 50143 | Lipids and lipid-like molecules | Glycero phospholipids | Glycero phosphocholines | 2.03 | 0.028 | up | Glycero phospholipid metabolism | Known as lysophospholipids which has a role in lipid signaling by acting on lysophospholipid receptors. |
Phosphocholine | C5H14 NO4P | C00588 | HMDB0 001565 | Organic nitrogen compounds | Organonitrogen compounds | Quaternary ammonium salts | 2.71 | 0.012 | up | Glyceropho spholipid metabolism | Known as choline phosphate, participates in a number of enzymatic reactions, can be converted into choline through its interaction with the enzyme phosphoethanolamine/phosphocholine phosphatase. | |
1-Phosphatidyl-D-myo-inositol | C11H1 9O13P | C01194 | HMDB00 06953 | LMGP06 010000 | Lipids and lipid-like molecules | Glyceropho spholipids | Glyceropho sphoinositols | 0.40 | 0.046 | down | Glyceropho spholipid metabolism | Unclear |
Graft Survival | ||||||||||||
Calcidiol | C27H 44O2 | C01561 | HMDB0 003550 | Lipids and lipid-like molecules | Steroids and steroid derivatives | Vitamin D and derivatives | 1.67 (1.21- 2.32) | 0.002 | Hazardous | Steroid biosynthesis | Major circulating metabolite of vitamin D3, produced in liver and the best indicator of the body’s vitamin D stores. Effective in treatment of rickets and osteomalacia. | |
Delta7-Avenasterol | C29H 48O | C15782 | HMDB00 06851 | LMST01 040154 | Lipids and lipid-like molecules | Steroids and steroid derivatives | Stigmastanes and derivatives | 1.31 (1.03-1.68) | 0.030 | Hazardous | Steroid biosynthesis | Known as delta7-Avenasterol as intermediate in biosynthesis of steroids, converted from 24-Ethylidenelophenol, then converted to 5-dehydroavenasterol in synthesis of Stigmasterol. |
Presqualene diphosphate | C30H52 O7P2 | C03428 | HMDB00 01278 | LMPR0106 010003 | Lipids and lipid-like molecules | Prenol lipids | Triterpenoids | 1.27 (1.08-1.64) | 0.045 | Hazardous | Steroid biosynthesis | Known as presqualene diphosphate as an intermediate in the biosynthesis of terpenoid. Substrate for farnesyl-diphosphate farnesyltransferase. |
Episterol | C28H46O | C15777 | HMDB00 06847 | LMST01 030115 | Lipids and lipid-like molecules | Steroids and steroid derivatives | Ergostane steroids | 1.08 (1.02-1.18) | 0.044 | Hazardous | Steroid biosynthesis | Involved in the biosynthesis of steroids. Converted from 24-Methylenelophenol to 5-Dehydroepisterol by lathosterol oxidase |
5-Dehydroepisterol | C28H44O | C15780 | HMDB00 06848 | LMST01 030135 | Lipids and lipid-like molecules | Steroids and steroid derivatives | Ergostane steroids | 1.59 (1.05-2.66) | 0.041 | Hazardous | Steroid biosynthesis | As an intermediate in the biosynthesis of steroids, converted from Episterol, then converted to 24-Methylenecholesterol. |
4,4-Dimethylcholesta-8,14,24-trienol | C29H46O | C11455 | HMDB0 001023 | Lipids and lipid-like molecules | Steroids and steroid derivatives | Cholestane steroids | 1.98 (1.07-3.69) | 0.031 | Hazardous | Steroid biosynthesis | Involved in the biosynthesis of steroids and involved in the conversion from lanosterol to zymosterol. |